|
2024
|
P/S
|
Pharmaceutical preparations. |
|
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of the central nervous system, namel... |
|
|
P/S
|
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal prep... |
|
|
P/S
|
Préparations pharmaceutiques pour la prévention et le traitement du système nerveux central, à sa... |
|
|
P/S
|
Ophthalmic surgery devices and instruments for controlled sub-retinal delivery of pharmaceutical,... |
|
|
P/S
|
Pharmaceutical and medical preparations; sanitary preparations for medical purposes; pharmaceutic... |
|
|
P/S
|
Pharmaceutical preparations and gene therapy products in the nature of injectable biologic prepar... |
|
|
P/S
|
Préparations pharmaceutiques pour le diagnostic et le traitement de maladies et de troubles oncol... |
|
|
P/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic ... |
|
|
P/S
|
Pharmaceutical preparations. Collection and preservation of biological tissue, blood and
cells; ... |
|
|
P/S
|
Providing access to an electronic exchange of medical records across a nationwide health informat... |
|
|
P/S
|
Préparations pharmaceutiques et produits de thérapie génique sous forme de préparations biologiqu... |
|
|
P/S
|
Pharmaceutical preparations and gene therapy products in the
nature of injectable biologic prepa... |
|
2023
|
Invention
|
Molecular glue degrader compounds and uses thereof. Described herein are molecular glue degrader ... |
|
|
Invention
|
Tricyclic compounds and their uses. 123455, y, R, M, W, L, V, T, Y, J, K and A are as described h... |
|
|
Invention
|
Methods of treating estrogen receptor-mediated disorders. The present disclosure provides methods... |
|
|
Invention
|
Combination therapy for the treatment of cancer.
The present disclosure relates to a pharmaceuti... |
|
|
Invention
|
Synthesis methods and intermediates for the production of remibrutinib. This invention relates to... |
|
|
Invention
|
Treatment of autoimmune disorders using chimeric antigen receptor therapy. The invention provides... |
|
|
Invention
|
Methods of making chimeric antigen receptor-expressing cells.
The invention provides methods of ... |
|
|
Invention
|
Amorphous solid dispersions comprising naporafenib. The present invention relates to the field of... |
|
|
Invention
|
Pyridine and pyrazine derivative for the treatment of cf, copd, and bronchiectasis.
The present ... |
|
|
Invention
|
Nlrp3 inflammasome inhibitors. The present invention relates to novel pyridazin-3-yl phenol compo... |
|
|
Invention
|
Nlrp3 inflammasome inhibitors.
The present invention relates to novel pyridazin-3-yl phenol comp... |
|
|
Invention
|
Treatment for acute organ injury using cd39, recombinant cd39. The present invention pertains to ... |
|
|
Invention
|
Improved production of cd39 variants. The present invention pertains to the use of miRNA technolo... |
|
|
Invention
|
Methods of treating metabolic disorders with fgf21 variants.
Provided herein are methods of trea... |
|
|
Invention
|
Silent fc variants of anti-cd40 antibodies.
The present invention relates to silent Fc variants ... |
|
|
Invention
|
Dosing regimen for a nlrp3 inhibitor. The present disclosure relates to the field of pharmacy, pa... |
|
|
Invention
|
Pharmaceutical compositions of tricyclic akr1c3 dependent kars inhibitor and methods for making s... |
|
|
Invention
|
Crystalline forms of an akr1c3 dependent kars inhibitor. This application relates to crystalline ... |
|
|
Invention
|
Methods of tricyclic akr1c3 dependent kars inhibitor dosing field of the invention. The present i... |
|
|
Invention
|
Treatment of aiha with baff or baff receptor inhibitory antibodies. The disclosure relates to a m... |
|
|
Invention
|
Novel fatty acids and their use in conjugation to biomolecules.
The invention provides a conjuga... |
|
|
Invention
|
Methods for treating hematologic cancers.
The present invention relates to methods of treating h... |
|
|
Invention
|
Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof.
The present... |
|
|
Invention
|
Dual-acting pharmaceutical compositions based on superstructures of angiotensin receptor antagoni... |
|
|
Invention
|
Octreotide depot formulation with constantly high exposure levels.
The present invention relates... |
|
|
Invention
|
Use of canakinumab.
The present invention relates to canakinumab for use in reducing the risk of... |
|
|
Invention
|
Car t cell therapies with enhanced efficacy.
The invention provides methods for manufacturing op... |
|
|
Invention
|
Methods of using il-1beta compounds.
This invention relates to methods employing IL-1 beta-ligan... |
|
|
Invention
|
Anti-ccr7 antibody drug conjugates.
This application discloses anti-CCR7 antibodies, antigen bin... |
|
|
Invention
|
Factor xi antibodies and methods of use.
The present invention relates to monoclonal antibodies ... |
|
2022
|
Invention
|
Pyrrolopyrimidine compounds and their uses.
The disclosed compounds relate to treatments and the... |
|
|
Invention
|
Combination therapies.
Combination therapies are disclosed. The combination therapies can be use... |
|
|
Invention
|
Compositions and methods to treat cancer.
The disclosure provides novel personalized therapies, ... |
|
|
Invention
|
Dosing regimens for sars-cov-2 binding molecules. The instant disclosure relates to compositions ... |
|
|
Invention
|
Nucleic acid molecules encoding chimeric antigen receptors comprising a cd20 binding domain. The ... |
|
2021
|
Invention
|
Pharmaceutical combinations comprising a kras g12c inhibitor and uses of a kras g12c inhibitor fo... |
|
|
Invention
|
Pyrrolo[3,2-b]pyridine derivatives useful in treating conditions associated with cgas.
The prese... |
|
|
Invention
|
Radiolabelled alpha-v beta-3 and/or alpha-v beta-5 integrins antagonist for use as theragnostic a... |
|
|
Invention
|
Reversal binding agents for anti-natriuretic peptide receptor i (npri) antibodies and uses thereo... |
|
|
Invention
|
Use of mglur5 antagonists for treating gambling disorder.
The present invention relates to the u... |
|
|
Invention
|
Use of mglur5 antagonists for treating amphetamine addiction.
The invention relates to the mavog... |
|
|
Invention
|
Dosage regimen for a nr2b-nmda receptor nam for the treatment of depression.
The invention relat... |
|
|
Invention
|
Mcl-1 inhibitor antibody-drug conjugates and methods of use.
Anti-CD48 antibody-drug conjugates ... |
|
|
Invention
|
Synthesis of prostate specific membrane antigen (psma) ligands.
The present disclosure relates t... |
|
|
Invention
|
Combination therapies with chimeric antigen receptor (car)-expressing cells.
This disclosure pro... |
|
|
Invention
|
Cd19 binding molecules and uses thereof.
The present disclosure provides CD19 binding molecules ... |
|
|
Invention
|
New crystalline forms of a kras g12c inhibitor compound.
Provided are crystalline forms of a KRA... |
|
2020
|
Invention
|
Methods for measuring cralbp activity.
The present disclosure provides methods for measuring act... |
|
|
Invention
|
Methods for treating ocular diseases.
A method is provided for treating a patient having a neova... |
